AstraZeneca hires former Sloan Kettering specialist to lead oncology R&D unit

The doctor resigned as Sloan Kettering's chief medical officer in September amid a controversy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.